TY - JOUR AU - Difeo, A. AU - Huang, F. AU - Sangodkar, J. AU - Terzo, E. A. AU - Leake, D. AU - Narla, G. AU - Martignetti, J. A. PY - 2009 DA - 2009// TI - Klf6-SV1 is a novel antiapoptotic protein that targets the BH3-only protein NOXA for degradation and whose inhibition extends survival in an ovarian cancer model JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-4282 DO - 10.1158/0008-5472.CAN-08-4282 ID - Difeo2009 ER - TY - JOUR AU - Banck, M. S. AU - Beaven, S. W. AU - Narla, G. AU - Walsh, M. J. AU - Friedman, S. L. AU - Beutler, A. S. PY - 2006 DA - 2006// TI - Klf6 degradation after apoptotic DNA damage JO - FEBS Letters VL - 580 UR - https://doi.org/10.1016/j.febslet.2006.10.077 DO - 10.1016/j.febslet.2006.10.077 ID - Banck2006 ER - TY - JOUR AU - Chen, C. AU - Hyytinen, E. -. R. AU - Sun, X. AU - Helin, H. J. PY - 2003 DA - 2003// TI - Deletion, mutation, and loss of expression of KLF6 in human prostate cancer JO - Am J Pathol VL - 162 UR - https://doi.org/10.1016/S0002-9440(10)63930-2 DO - 10.1016/S0002-9440(10)63930-2 ID - Chen2003 ER - TY - JOUR AU - Benzeno, S. AU - Narla, G. AU - Allina, J. AU - Cheng, G. Z. AU - Reeves, H. L. AU - Banck, M. S. PY - 2004 DA - 2004// TI - Cyclin-dependent kinase inhibition by the Klf6 tumor suppressor protein through interaction with cyclin D1 JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-03-2818 DO - 10.1158/0008-5472.CAN-03-2818 ID - Benzeno2004 ER - TY - JOUR AU - Reeves, H. L. AU - Narla, G. AU - Ogunbiyi, O. AU - Haq, A. I. AU - Katz, A. AU - Benzeno, S. PY - 2004 DA - 2004// TI - Kruppel-like factor 6 (Klf6) is a tumor-suppressor gene frequently inactivated in colorectal cancer JO - Gastroenterology VL - 126 UR - https://doi.org/10.1053/j.gastro.2004.01.005 DO - 10.1053/j.gastro.2004.01.005 ID - Reeves2004 ER - TY - JOUR AU - Kremer-Tal, S. AU - Reeves, H. L. AU - Narla, G. AU - Thung, S. N. AU - Schwartz, M. AU - Difeo, A. PY - 2004 DA - 2004// TI - Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (Klf6) in hepatocellular carcinoma JO - Hepatology VL - 40 UR - https://doi.org/10.1002/hep.20460 DO - 10.1002/hep.20460 ID - Kremer-Tal2004 ER - TY - JOUR AU - DiFeo, A. AU - Martignetti, J. A. AU - Narla, G. PY - 2009 DA - 2009// TI - The role of KLF6 and its splice variants in cancer therapy JO - Drug Resist Updat VL - 12 UR - https://doi.org/10.1016/j.drup.2008.11.001 DO - 10.1016/j.drup.2008.11.001 ID - DiFeo2009 ER - TY - JOUR AU - Liang, W. -. c. AU - Wang, y. AU - Xiao, L. -. J. AU - Wang, y. -. B. PY - 2014 DA - 2014// TI - Identification of miRNAs that specifically target tumor suppressive Klf6-FL rather than oncogenic Klf6-SV1 isoform JO - RNa Biol VL - 11 UR - https://doi.org/10.4161/rna.29356 DO - 10.4161/rna.29356 ID - Liang2014 ER - TY - JOUR AU - Narla, G. AU - Difeo, A. AU - Reeves, H. L. PY - 2005 DA - 2005// TI - A germline DNA polymorphism associated with increased prostate cancer risk enhances alternative splicing of the KLF6 tumor suppressor gene JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-4249 DO - 10.1158/0008-5472.CAN-04-4249 ID - Narla2005 ER - TY - JOUR AU - Racca, A. C. AU - Ridano, M. E. AU - Bandeira, C. L. AU - Bevilacqua, E. AU - Avvad Portari, E. AU - Genti-Raimondi, S. AU - Graham, C. H. AU - Panzetta-Dutari, G. M. PY - 2016 DA - 2016// TI - Low oxygen tension induces Krüppel-Like Factor 6 expression in trophoblast cells JO - Placenta VL - 45 UR - https://doi.org/10.1016/j.placenta.2016.07.006 DO - 10.1016/j.placenta.2016.07.006 ID - Racca2016 ER - TY - JOUR AU - Humbert, M. AU - Halter, V. AU - Shan, D. AU - Laedrach, J. AU - Leibundgut, E. O. AU - Baerlocher, G. M. AU - Tobler, A. AU - Fey, M. F. AU - Tschan, M. P. PY - 2011 DA - 2011// TI - Deregulated expression of Kruppel-like factors in acute myeloid leukemia JO - Leuk Res VL - 35 UR - https://doi.org/10.1016/j.leukres.2011.03.010 DO - 10.1016/j.leukres.2011.03.010 ID - Humbert2011 ER - TY - JOUR AU - Hanoun, N. AU - Bureau, C. AU - Diab, T. PY - 2010 DA - 2010// TI - The SV2 variant of Klf6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions JO - J Hepatol VL - 53 UR - https://doi.org/10.1016/j.jhep.2010.04.038 DO - 10.1016/j.jhep.2010.04.038 ID - Hanoun2010 ER - TY - JOUR AU - D’Astolfo, D. S. AU - Gehrau, R. C. AU - Bocco, J. L. AU - Koritschoner, N. P. PY - 2008 DA - 2008// TI - Silencing of the transcription factor Klf6 by siRNA leads to cell cycle arrest and sensitizes cells to apoptosis induced by DNA damage JO - Cell Death Differ VL - 15 UR - https://doi.org/10.1038/sj.cdd.4402299 DO - 10.1038/sj.cdd.4402299 ID - D’Astolfo2008 ER - TY - JOUR AU - Sirach, E. AU - Bureau, C. AU - Peron, J. M. AU - Pradayrol, L. AU - Vinel, J. P. AU - Buscail, L. AU - Cordelier, P. PY - 2007 DA - 2007// TI - Klf6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis JO - Cell Death Differ VL - 14 UR - https://doi.org/10.1038/sj.cdd.4402114 DO - 10.1038/sj.cdd.4402114 ID - Sirach2007 ER - TY - JOUR AU - Jakob, L. ´. n. AU - Hoke, H. A. AU - Lin, C. Y. AU - Lau, A. AU - Orlando, D. A. AU - Vakoc, C. R. AU - Bradner, J. E. AU - Lee, T. I. AU - Young, R. A. PY - 2013 DA - 2013// TI - Selective inhibition of tumor oncogenes by disruption of super enhancers JO - Cell VL - 153 UR - https://doi.org/10.1016/j.cell.2013.03.036 DO - 10.1016/j.cell.2013.03.036 ID - Jakob2013 ER - TY - JOUR AU - Mansour, M. R. AU - Abraham, B. J. AU - Anders, L. AU - Berezovskaya, A. AU - Gutierrez, A. AU - Durbin, A. D. AU - Etchin, J. AU - Lawton, L. PY - 2014 DA - 2014// TI - An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element JO - Science VL - 346 UR - https://doi.org/10.1126/science.1259037 DO - 10.1126/science.1259037 ID - Mansour2014 ER - TY - JOUR AU - Bannikov, A. V. AU - Lavrov, A. V. PY - 2017 DA - 2017// TI - CRISPR/CAS9, the king of genome editing tools JO - Mol Biol VL - 51 UR - https://doi.org/10.1134/S0026893317040033 DO - 10.1134/S0026893317040033 ID - Bannikov2017 ER - TY - JOUR AU - Pougach, K. S. AU - Lopatina, A. V. AU - Severinov, K. V. PY - 2012 DA - 2012// TI - CRISPR adaptive immunity systems of prokaryotes JO - Mol Biol VL - 46 UR - https://doi.org/10.1134/S0026893312020136 DO - 10.1134/S0026893312020136 ID - Pougach2012 ER - TY - JOUR AU - Zhigalova, N. A. AU - Zhenilo, S. V. AU - Artemov, A. V. AU - Prokhortchouk, E. B. PY - 2017 DA - 2017// TI - CRISPR/Cas9-editing-based modeling of hypoxia in renal cancer cells JO - Mol Biol VL - 51 UR - https://doi.org/10.1134/S0026893317050235 DO - 10.1134/S0026893317050235 ID - Zhigalova2017 ER - TY - JOUR AU - Ri, K. C. AU - Kim, K. C. AU - Kong, S. H. AU - Ri, J. H. PY - 2018 DA - 2018// TI - The disruption of Klf6-related super-enhancer induces growth inhibition and apoptosis in human HepG2 Cells JO - Genet Mol Res VL - 17 ID - Ri2018 ER - TY - JOUR AU - Ri, K. C. AU - Kim, J. S. AU - Kim, C. PY - 2017 DA - 2017// TI - Identification ofKlf6-related super enhancer in human hepatoma (HepG2) cells by CRISPR technique JO - Genet Mol Res VL - 16 ID - Ri2017 ER - TY - JOUR AU - Brummelkamp, T. R. AU - Bernards, R. AU - Agami, R. PY - 2002 DA - 2002// TI - A system for stable expression of short interfering RNAs in mammalian cells JO - Science VL - 296 UR - https://doi.org/10.1126/science.1068999 DO - 10.1126/science.1068999 ID - Brummelkamp2002 ER - TY - JOUR AU - Hatami, R. AU - Sieuwerts, A. M. PY - 2013 DA - 2013// TI - KLF6-SV1 drives breast cancer metastasis and is associated with poor survival JO - Sci Transl Med VL - 5 UR - https://doi.org/10.1126/scitranslmed.3004688 DO - 10.1126/scitranslmed.3004688 ID - Hatami2013 ER - TY - JOUR AU - Kremer-Tal, S. AU - Narla, G. PY - 2007 DA - 2007// TI - Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation JO - J Hepatol VL - 46 UR - https://doi.org/10.1016/j.jhep.2006.10.012 DO - 10.1016/j.jhep.2006.10.012 ID - Kremer-Tal2007 ER - TY - JOUR AU - Cong, L. AU - Ran, F. A. AU - Cox, D. AU - Lin, S. AU - Barretto, R. PY - 2013 DA - 2013// TI - Multiplex genome engineering using CRISPR/Cas systems JO - Science VL - 339 UR - https://doi.org/10.1126/science.1231143 DO - 10.1126/science.1231143 ID - Cong2013 ER - TY - JOUR AU - Didych, D. A. AU - Tyulkina, D. V. AU - Pleshkan, V. V. AU - Alekseenko, I. V. AU - Sverdlov, E. D. PY - 2015 DA - 2015// TI - Are super-enhancers regulators of regulatory genes of development and cancer JO - Mol Biol VL - 49 UR - https://doi.org/10.1134/S0026893315060059 DO - 10.1134/S0026893315060059 ID - Didych2015 ER - TY - JOUR AU - Hnisz, D. AU - Abraham, B. J. AU - Lee, T. I. AU - Lau, A. AU - Saint-Andre, V. AU - Sigova, A. A. AU - Hoke, H. A. AU - Young, R. A. PY - 2013 DA - 2013// TI - Super-enhancers in the control of cell identity and disease JO - Cell VL - 155 UR - https://doi.org/10.1016/j.cell.2013.09.053 DO - 10.1016/j.cell.2013.09.053 ID - Hnisz2013 ER - TY - JOUR AU - Hnisz, D. AU - Schuijers, J. AU - Lin, C. Y. AU - Weintraub, A. S. AU - Abraham, B. J. AU - Lee, T. I. AU - Bradner, J. E. AU - Young, R. A. PY - 2015 DA - 2015// TI - Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers JO - Mol Cell VL - 58 UR - https://doi.org/10.1016/j.molcel.2015.02.014 DO - 10.1016/j.molcel.2015.02.014 ID - Hnisz2015 ER - TY - JOUR AU - Narla, G. AU - DiFeo, A. AU - Yao, S. AU - Banno, A. PY - 2005 DA - 2005// TI - Targeted Inhibition of the Klf6 splice variant, Klf6 SV1, suppresses prostate cancer cell growth and spread JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-0217 DO - 10.1158/0008-5472.CAN-05-0217 ID - Narla2005 ER -